Reg FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549       FORM  8-K       CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       Date of Report (Date of earliest event reported): February 1, 2023   VEECO INSTRUMENTS INC. (Exact name of registrant as specified in its charter)   Delaware (State or other jurisdiction of incorporation) 0-16244 (Commission File Number) 11-2989601 (IRS Employer Identification No.)   Terminal Drive , Plainview , New York 11803 (Address of principal executive offices)   ( 516 ) 677-0200  (Registrant’s telephone number, including area code)   Not applicable  (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share VECO The NASDAQ Global Select Market    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 7.01 Regulation FD Disclosure   On February 1, 2023, Veeco Instruments Inc. issued a press release announcing its acquisition of Epiluvac AB based in Sweden. A copy of the press release is furnished as Exhibit 99.1 to this report.   The information furnished pursuant to this Item 7.01 and Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall it be deemed incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.   Item 9.01 Financial Statements and Exhibits   (d) Exhibits   Exhibit No.   Description 99.1   Press release issued by Veeco dated February 1, 2023       104   Cover Page Interactive Data File (embedded within the Inline XBRL document)   2     SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   February 1, 2023 VEECO INSTRUMENTS INC.       By: /s/ Kirk Mackey   Name: Kirk Mackey   Title: Vice President, General Counsel   3